Friday, April 11, 2025

💹 Your Post-Notable Earnings Report (Apr 11)

Open Email...Your Morning Report Inside…Post Earnings for Major Stocks
Your Notable Earnings Report

Unsubscribe

This One Company Could Disrupt the Entire Pharmaceutical Industry (ad)*
Dear Reader,
I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities).

This Revolutionary Biotech Just Hit the NASDAQ (ad)*
The drugs we've been taking for years are due for a major upgrade and THIS company is making it happen. It is aiming for FDA approval of its sublingual aspirin products, and after a recent Wall Street debut, now may be the ideal time to have the company on your watch list!
Click here for the name and ticker symbol

Symbol CompanyEarning DateEPS Surprise %
STZ04/09 before 15.35%
DAL04/09 before 15.00%
TLRY04/08 before -150.00%
WBA04/08 before 18.87%
PLAY04/07 before 7.81%
CAG04/03 before -1.92%
BB04/02 before 200.00%
RH04/02 After -17.28%
NNOX03/31 before %
GWH03/31 After -30.46%
ANY03/28 before -7.41%
CODX03/27 before -5.88%
LULU03/27 before 4.96%
TMC03/27 After 16.67%
DDD03/26 before -25.00%
Click Here to View Your Full Report
sun Before Market Opensun After Market Close

This Nasdaq-Listed Biopharma Company is shaping the future of medicine. (ad)*
With an innovative drug delivery mechanism that aims to help save millions of lives with its first to market product. The Company has assembled a world class team and is led by a CEO who has achieved more than $1B market caps on not one, but two previous companies!
Click here for the full story.

Investors Pay Attention: FDA Fast-Track Potential – Aspire's aspirin formulation is eligible for the FDA's 505(b)(2) pathway (ad)*
With its innovative tech and a massive global market, this Nasdaq-listed biopharma Company is ready to lead the future of medicine.
Click Here to Learn More >>>

How to use EPS Surprice in your Post-Earnings trading strategies:
Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on Ride-the-Wave Strategy to learn more about it.
Stock Trading - If you're a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company.
At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.
To your trading success,
Support Team
Daily Options Signals
PS: Daily Options Signals is morning newsletter, powered by StockEarnings proprietary technology.
The Ultimate Options Trading Guide For Beginners to Advanced
Veteran trader reveals strategies for navigating market-moving announcements.
Click Here and Get Your eBook "The Ultimate Options Trading Guide" for Free before this opportunity vanishes!

(ad)* This message is a PAID ADVERTISEMENT for Aspire Bio Labs (NASDAQ: ASBP) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $10,000 for multiple Dedicated Email Sends, Newsletter Sponsorship, and SMS sends between April 11, 2025 and April 17, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Aspire Bio Labs (NASDAQ: ASBP) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Aspire Bio Labs (NASDAQ: ASBP) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and Aspire Bio Labs (NASDAQ: ASBP).

Daily Options Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

StockEarnings Inc. 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS

Unsubscribe


Today's Bonus Content: Unlock Hidden Gems with Our Free Wealth Building Report!

(By clicking this link, you are subscribing to receive emails from Krypton Street Newsletter)

No comments:

Post a Comment